Carla Baan

Carla Baan is a Full Professor in the Department of Internal Medicine at Erasmus MC, Faculty of Medicine. Her research is centered on transplant immunology, with a strong focus on kidney transplantation, immune monitoring, and immunosuppressive strategies. She leads a dynamic research group contributing significantly to understanding immune responses post-transplant.

Research interests include T cell immunology, mesenchymal stem cells, acute graft rejection, and the role of extracellular vesicles in transplantation. Her work bridges clinical practice and translational science, aiming to improve graft survival and patient outcomes. She actively investigates novel immunosuppressive regimens and immune biomarkers for early detection of rejection.

The recent publications reflect a strong trend in clinical and mechanistic immunology, particularly in modulating immune responses post-kidney transplant. Topics span from urinary extracellular vesicles as rejection biomarkers to pharmacological manipulation of immune cells (e.g., BCL6 inhibition) and enhancing vaccine efficacy in immunocompromised recipients. These studies emphasize translational research, often involving randomized trials and biomarker validation.

While no specific scientific awards are listed in the provided text, her extensive publication record and leadership in high-impact clinical research suggest significant recognition in the field. She has supervised 26 academic works, indicating an active role in mentoring the next generation of researchers. Though no grants are explicitly mentioned, her involvement in multi-center trials (e.g., RECOVAC Consortium) implies successful grant funding and collaborative leadership.

Dr. Baan is involved in advanced research on immune monitoring and regenerative medicine approaches in transplantation, including work with kidney organoids and gene therapy. Her team collaborates widely across national and international networks, focusing on improving long-term outcomes in transplant recipients through innovative immunomodulatory strategies.